Class Action Article

  • File A Talcum Powder Lawsuit: Talcum Powder Ovarian Cancer Lawsuits Talcum Powder Fallopian Tube Cancer Lawsuits Baby  Powder Ovarian Cancer Lawsuits Filed If you or a loved one used talcum powder products and were diagnosed with ovarian cancer, or fallopian tube can...

Class Action News

Drug Class Actions

  • Taxotere Lawyers for Permanent Hair Loss: Taxotere Baldness Lawyers For  Permanent Hair Loss Lawsuits Have you received Taxotere for breast cancer? Taxotere can result in hair loss or baldness  that is permanent. Taxotere  is a chemotherapy drug used for the treatment of breas...

Medical Device Lawsuits

  • Zimmer Hip Replacement Lawyers: Network Zimmer Hip Replacement  Lawyer Win $2 Million Against Zimmer Hip Replacement Do You Have A Faulty Zimmer M/L Taper Hip Prothesis With Connective Technology and Cobalt Chromium Head? Do You Have Have Metallosis or Chromium Cobalt T...

Multi District Litigation Requested For Invokana

Written by lisaspitzer on . Posted in Alabama Multidistrict Litigation Lawyers, Anaheim, Atlanta, Baltimore, Charleston, Charlotte, Class MDL Class Action News, Dallas, Denver, Fort Lauderdale, Houston, Invokana lawsuit, Invokana lawyer, Invokana Lawyers, Kansas city, Ketoacidosis Lawyer, Las Vegas, Los Angeles, Louisville, Macon, Miami, Minneapolis, North Carolina Multidistrict Litigation Lawyers, NYC, NYC Class Action Lawyers, Philadelphia, Phoenix, Provo, Raleigh-Durham, Reno, Sarasota, Seattle, st louis, Toledo, West Palm Beach, Xarelto Lawyer, Xarelto Lawyers

A Multi District Litigation has been requested for the consolidation of the Invokana lawsuits by Invokana lawyers as lawsuits continue to increase. A consolidation is requested to facilitate proceeding under one judge and jurisdiction. The  lawsuits against the manufacturer of the diabetes drug Invokana are alleging serious injuries after taking Invokana, including heart attack, kidney damage and a dangerous blood condition known as ketoacidosis. The  lawsuits claim that  Johnson & Johnson and its  subsidiary Janssen failed to warn patients and doctors  about the risks of taking Invokana. Invokana lawyers filed a  motion on September 20 asking the U.S. Judicial Panel on Multidistrict Litigation to  consolidate Invokana lawsuits. The formation of an MDL would transfer all cases to a single judge and jurisdiction. Invikana lawyers explained in the motion that the  FDA had received many reports of kidney damage as a result of patients taking Invokana, which led the FDA to issue a stronger  Invokana warning risk with a June 2016 label change. That warning was preceded by another label change in May 2015, alerting users to the risk of ketoacidosi. Ketoacidoasis can be a life-threatening condition that occurs when blood acids known as ketones reach dangerously high levels. Additional warnings were added to the label in August 2016, noting that fatal cases of ketoacidosis had been reported with Invokana use. What Is Invokana? Invokana is a diabetes drug in the   SGLT2 inhibitor category. It  regulate blood sugar levels by encouraging the body to eliminate extra glucose in urine. Consolidation has been requested for the  District Court of New Jersey in Trenton, where 36 of the Invokana lawsuits are already pending. All of those cases are before Judge Brian R. Martinotti, a federal judge the motion notes has extensive experience with complex litigation. If you or a loved one has  had a life threatening event due to Invokana call out Invokana Helpline today.  

Tags: , , , , , , , , , , ,